Truveta achieves HITRUST r2 Certification, demonstrating the highest level of information protection assurance
November 20, 2024 09:00 ET
|
Truveta
BELLEVUE, Wash., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Truveta announced that its platform Truveta Studio and Truveta Data have earned certified status by HITRUST for information security. This...
Truveta Data, the most complete, timely, and clean electronic health record data, now includes more than 120 million de-identified patients
November 14, 2024 09:53 ET
|
Truveta
BELLEVUE, Wash., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Truveta announced today that Truveta Data, the most complete, timely, and clean electronic health record (EHR) data, now includes more than 120...
Truveta Studio now includes Truveta Tru, a research assistant powered by generative AI
October 29, 2024 09:18 ET
|
Truveta
BELLEVUE, Wash., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Today, Truveta announced its latest AI innovation – Truveta Tru, Truveta Studio’s research assistant powered by generative AI. Trained on the...
The CHOICE Institute partners with Truveta to advance health economics and outcomes research
September 04, 2024 09:00 ET
|
Truveta
BELLEVUE and SEATTLE, Wash., Sept. 04, 2024 (GLOBE NEWSWIRE) -- The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy has...
Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss published in JAMA Internal Medicine
July 08, 2024 11:16 ET
|
Truveta
BELLEVUE, Wash., July 08, 2024 (GLOBE NEWSWIRE) -- Today Truveta announced that its comparative effectiveness study exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide...
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities
June 18, 2024 11:13 ET
|
Truveta
BELLEVUE, Wash., June 18, 2024 (GLOBE NEWSWIRE) -- Today, Truveta announced regulatory and audit capabilities to support its customers for real-world evidence (RWE) submissions to the Food and Drug...
Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair
May 13, 2024 09:00 ET
|
Truveta
BELLEVUE, Wash., May 13, 2024 (GLOBE NEWSWIRE) -- Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data, welcomes Rod Hochman, MD, president and...
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance research
May 02, 2024 09:00 ET
|
Truveta
BELLEVUE, Wash., May 02, 2024 (GLOBE NEWSWIRE) -- Today Truveta announced the availability of expanded concepts from clinical notes -- including family history, medication details reported to...
CDC awards Truveta a real-world data contract to study COVID, maternal health, and pediatric care
January 22, 2024 09:00 ET
|
Truveta
BELLEVUE, Wash., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Today, Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was awarded a contract with the U.S....
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research
November 08, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced the availability of more than 56.6 million clinical observations from more than 2.7 million echocardiogram reports from...